|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Evet (Yes)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
26.06.2025
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
-Unofficial Translation- The construction of the Solar Power Plant (SPP) project, located in the Babaeski district of Kırklareli province with an installed capacity of 2.3 MW , has been completed. This project was carried out by Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GEN) in line with our sustainability and financial efficiency targets. The official acceptance of the aforementioned SPP has been conducted by Türkiye Elektrik Dağıtım A.Ş. (TEDAŞ) , and the formal acceptance letter has been served to our company. With this addition, GEN's total installed capacity has reached 16.87 MW , increasing from our previous capacity of 14.57 MW . Consequently, nearly all of the electricity consumed by our company can now be met through renewable energy sources. The SPP investments are anticipated to lead to a significant reduction in GEN's carbon emissions. Furthermore, the decrease in electricity expenses is expected to provide an improvement in the EBITDA margn . In case of any discrepancy between the Turkish and English texts, the Turkish text shall prevail. |
||||||||